Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Glioblastoma × Ipilimumab × Clear all

Phase

Phase 1 5 Phase 2 4 Phase 1/2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 18 Carcinoma, Non-Small-Cell Lung 10 Carcinoma, Renal Cell 9 Kidney Neoplasms 4 Stomach Neoplasms 3 Mesothelioma 3 Lung Neoplasms 3 Diabetes Mellitus, Insulin-Dependent, 12 3 Carcinoma, Hepatocellular 3 Skin Neoplasms 2 Prostatic Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Various Advanced Cancer 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Non-Small Cell Lung Cancer Metastatic 1 Neoplasms 1 Melanoma, Cutaneous Malignant 1 Lymphatic Metastasis 1

Interventions

Temozolomide 39 Radiotherapy 18 Lomustine 12 Bevacizumab 11 Carmustine 8 Radiation 7 Procarbazine 4 Magnetic Resonance Spectroscopy 4 Surgical Procedures, Operative 3 pembrolizumab 2 depatuxizumab mafodotin 2 Tf-CRM107 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Drug Therapy 2 Dihematoporphyrin Ether 2 DNA Methylation 2 Carboplatin 2 ABT-414 2 trans-sodium crocetinate 1 tofacitinib 1 sargramostim 1 rindopepimut 1 niraparib 1 marizomib 1 enzastaurin 1 edotecarin 1 contrast agent BR1 1 cediranib 1 carmustine, poliferprosan 20 drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02017717 2025-04-04

CheckMate 143

Bristol-Myers Squibb

Phase 3 Completed

529 enrolled 28 charts

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡